A Formaldehyde Sampling Strategy for a Medical Center by Bernatzky, James E.
ABSTRACT
The uses of formaldehyde in a medical center, commercial
availability, and possible health effects of exposure are
discussed.  The new OSHA standard and the need for this
study are presented.
Formaldehyde usage is classified according to type,
location, and amount of use.  A sampling strategy was
developed to determine possible exposures throughout the
medical center. Available sampling methods and analytical
procedures are listed and those chosen are discussed.
Sample results are presented by area according to type
of use.  A brief discussion of operations being carried out
in each area and a summary of sampling results are given.
Results of almost all formaldehyde sampling were below new
OSHA standards.  For those above prescribed OSHA levels, all
follow-up samples were below the standard after implementing
administrative controls.  Recommendations are made to help
with continued formaldehyde sampling at the medical center.
The medical center is currently in compliance with the
new OSHA requirements.  Reliable, efficient, and cost
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I.  INTRODUCTION
A. Formaldehyde is one of the most widely used chemicals in
industrial and laboratory settings.   It is used as a
preservative, a hardening and reducing agent, a corrosion
inhibitor, and in the manufacturing of resins and other
compounds.  In industry, it can be used in the manufacturing
of textiles, fertilizers, inks, glue, paper, wood, rubber,
and pharmaceuticals.  In health related occupations it is
used by pathologists, autopsy technicians, morticians,
anatomists, nurses, and surgeons for tissue preservation,
sterilization, and decontamination.  It has been estimated
that up to one-third of all people occupationally exposed
are in medical or other health related services.   Its wide
and extensive use in the medical setting is due to its
attributes as a fixative, preservative, disinfectant, and
decontaminating agent.
B. Formaldehyde was first synthesized in 1859 by Alexander
Butlerov.  Nine years later A.W. Hoffman identified
formaldehyde when he passed an air-methanol mixture over a
hot platinum spiral. The commercial manufacturing of
formaldehyde began in 1889 and had reached over five billion
g
pounds per year by 1986.
Formaldehyde is a colorless gas that is available
commercially in saturated solutions of 37.0 to 40.0% of
formaldehyde gas by weight in water.  The solution is
commonly called formalin and is considered 100.0% formalin,
therefore one part formalin in nine parts of water is not a
4.0% solution but a 10.0% solution.  Commercial formalin
usually contains 10.0 to 15.0% methanol to increase shelf
life and keep formaldehyde from combining with oxygen to
produce formic acid.
C.  Fixing fluids act as tissue preservatives, inhibiting
autolytic changes and bacterial growth.   Fixatives help to
harden tissue by either crosslinking or denaturing and
precipitating protein in them.  They also inactivate the
enzymes of cells, thereby avoiding digestion of proteins and
other macromolecular substances in the cell which would lead
to postmortem degeneration of tissue.   Fixatives also kill
bacteria and other disease causing organisms which might be
present in the tissue.
A 10.0% buffered formalin solution is the most popular
fixing agent in laboratories.  Formalin's advantages include
that it is relatively inexpensive, penetrates rapidly, does
not overharden tissue, preserves fatty tissue, and permits
the use of a wide assortment of staining methods.
For larger specimens, as in whole bodies, embalming
prevents bacterial and enzymatic decomposition of tissues.
The fixative is distributed to all parts of the body via the
circulatory system.  The use of formaldehyde for embalming
purposes increased dramatically when toxic metallic salts
4
were banned in the late 1800's.   Embalming fluids typically
contain 2.0% formalin, 2.0% phenol (to counteract the
formaldehyde bleaching effect), 6.0% glycerin (to soften
tissue and retard drying), 20.0% of 95.0% alcohol, and 70.0%
water.
Formaldehyde has long been used as a disinfectant.  The
application of formaldehyde for inactivation of
microorganisms was practiced before the turn of the
5
century.   One of the first uses of formaldehyde vapor was
6to fumigate sick rooms.
Formaldehyde is believed to inactivate bacteria, fungi,
molds, and yeasts by combining with amino groups of
proteins. In dilutions of 0.5 to 0.75%, formaldehyde kills
aerobic bacteria in six to twelve hours and anaerobic
bacteria in two to four days.  It is used in place of heat
sterilization in hemodialysis units to sterilize the
dialysis machines.  This is done by adding approximately
140.0 milliliters (mi's) of a 5.0% formalin solution to the
machine through a suction line and letting it sit overnight.
In some machines approximately 10.0 to 15.0 mi's of 37.0%
formaldehyde is sucked in and left overnight.
Formaldehyde is also used to decontaminate biological
safety cabinets, incubators, refrigerators, laboratory
rooms, or other enclosed spaces.  It has become the chemical
7
of choice for space disinfection.
Formaldehyde can be generated from aqueous formalin
solutions containing 37.0 to 40.0% formaldehyde by heating
or vaporizing the solution or by mixing potassium
permanganate to formalin in a 40:60% by weight volume ratio
to cause an exothermic chemical reaction.  Sodium
dichromate, bleaching powder, potassium or sodium chlorate,
or caustic soda can be used with appropriate ratios in place
of potassium permanganate.  The preferred method of
generating formaldehyde gas is by heating paraformaldehyde,
which is a solid polymer containing 91.0 to 99.0%
formaldehyde.  Heating is done in an electric frying pan or
deep fat cooker at temperatures above 150.0 degrees
centigrade in an atmosphere of 21.0 degrees centigrade or
greater and a relative humidity of 60.0% of more.
For restricted laboratories where infectious agents are
being used, decontamination must be done when that area is
to become an unrestricted general use laboratory.  In the
case of biological safety cabinets, a routine performance
certification may be necessary every six to twelve months.
A decontamination of the cabinet must be done if infectious
agents were used in order to enter the cabinet at minimal
risk of infection.  In the subject study, extensive
formaldehyde sampling was done during the decontamination of
biological safety cabinets and will be discussed in greater
detail later.
Formalin is also used on a smaller scale for such
operations as animal perfusions, northern blot gel
preparation, pap smear samples, and blood sample tray
preparation.  In all these cases a 10.0% buffered formalin
solution is used, either pre-made by the Pharmacy Department
or diluted as needed prior to use.
II.  HEALTH EFFECTS
Various health effects of inhalation and dermal contact
with formaldehyde have been reported.  Formaldehyde is a
primary irritant, it is toxic, and it is regarded as an
occupational carcinogen.  Responses have been produced upon
ingestion, inhalation, and adsorption through the skin.
Symptoms range from minor eye irritation to pulmonary edema
and death upon ingestion.
A.  Among the first symptoms seen are burning of the eyes
(lacrimation) and irritation of the upper respiratory tract.
Airborne concentrations as low as 0.1 parts per million
(ppm) can cause eye, nose, and throat irritation.   Stephens
used human subjects to determine an eye irritation threshold
of 1.0 ppm for five minutes.   Morrill determined the
threshold for eye irritation to be between 0.9 and 1.6 ppm
and bourne and Seferian reported eye irritations at
concentration as low as 0.13 to 0.45 ppm.   This threshold
limit may be impossible to determine quantitatively due to
variation in individual responses, but most studies seem to
support the lower ranges reported by Bourne and Seferian.
The inhalation of high concentrations of formaldehyde
can be extremely dangerous. A concentration of 100.0 ppm is
immediately dangerous to life and health (IDLH) and is
potentially fatal if exposure continues for thirty minutes
or more.
B.  It has been noted that dermal diseases and disorders
account for over a third of all reportable occupational
diseases, and are a serious problem in the United States
12
workplace.   Formaldehyde is one of the most common causes
12of occupational skin disease.   The major effects of
formaldehyde on the skin are the development of both
irritant dermatitis and sensitization leading to allergic
. 13contact dermatitis.  It may also cause urticaria (hives).
Irritant dermatitis results from a direct injury to the
skin and is more prone to occur or persist in atopic
individuals, encompassing 20.0 to 30.0% of the general
14
population.   Cases of primary skin irritation due to
contact with formaldehyde have included erythema,
inflammation of skin folds, decay of fingernails, and
urticaria.  Irritant reactions are more likely to occur
under conditions of low humidity, repeated wetting and
drying of the skin, temperature extremes, mechanical trauma,
pre-existing skin disease, and concomitant exposure to other
irritating substances. Repeated exposure to formaldehyde
15can cause development of hypersensitivity.
According to Rostenberg, a 10.0% solution of formalin is
a potential eczematous sensitizer.    Patch tests using 0.5%
formaldehyde showed positive responses in five nurses who
had developed papules and vesicles on their fingers and
faces after handling thermometers kept in a 10.0% formalin
solution.  Horsfall showed that 10.5 ppm of formaldehyde in
17
air can produce skin effects in sensitive individuals.
Experiments by Jordan showed that the level of formaldehyde
in liquid products must be reduced to 0.3% before the
18
majority of sensitized individuals can tolerate them.
Once sensitized, a person may react to skin contact with any
form of formaldehyde released from resins or other
compounds.
C.  Formaldehyde is readily absorbed in the respiratory
system when inhaled because of its high solubility and
reactivity.  It is thought that the upper respiratory tract
removes 95.0% of airborne formaldehyde and only 5.0% reaches
the bronchioles.   This is supported by the fact that most
of the effects of formaldehyde on the respiratory system are
in the upper portion of the tract.  Inhalation of
formaldehyde has been shown to cause ciliostasis of the
tracheal mucosa which could hinder the respiratory system's
ability to deal with environmental insults.  Interstitial
inflammation of the lungs of various animals upon exposure
20
to formaldehyde was shown by Coon.   Kane and Alarie have
demonstrated a decrease in respiratory rates in mice, which
21
is a characteristic of exposure to irritants.   It was
found by Amdur that guinea pigs exposed to 0.3 ppm to 50.0
ppm of formaldehyde had increased resistance to air flow and
22
reduced compliance of the lungs.   Histopathologic changes
were found in the nasal turbinates of rats exposed to
formaldehyde concentrations from 2.0 to 15.0 ppm for thirty
hours per week over an eighteen month period.  Epithelial
dysplasia and squamous metaplasia were found in many rats at
all exposure levels.  Inflammation of nasal mucous membranes
23
was found m some exposed animals.
D.  Long term inhalation of formaldehyde gas is associated
with nasal cancer in experimental animals.   Some studies
in humans exposed to formaldehyde have demonstrated
increased nasal and nasopharygeal cancer.^^ In 1983 the
American Conference of Governmental Industrial Hygienists
(ACGIH) determined formaldehyde to be a suspect human
carcinogen and in 1987 the Environmental Protection Agency
(EPA) classified formaldehyde as a "Bl probable human
carcinogen." This has led the Occupational Safety and
Health Administration (OSHA) to regard formaldehyde as an
occupational carcinogen.
Preliminary results were released in 1980 by the
Chemical Industry Institute of Toxicology (CUT) from a
chronic toxicity and carcinogenicity study of inhaled
24
formaldehyde m rats and mice.   These results showed that
rats exposed to 15.0 ppm formaldehyde for six hours per day.
10
five days per week over eighteen months developed squamous
cell carcinomas of the nasal cavities.  The study was
completed in 1981 and final results published in 1983 showed
nasal cancers in rats exposed to 5.6 and 14.3 ppm, benign
nasal tumors in rats exposed to 2.0 ppm, and nasal cancer in
mice exposed to 14.3 ppm formaldehyde for six hours per day,
25
five days per week for twenty-four months.
In a separate study done by researchers at New York
University, twenty-five out of one hundred rats developed
squamous cell carcinomas of the nasal cavity after exposure
to 14.0 ppm formaldehyde for six hours per day over 814
days, corroborating CIIT's finding that formaldehyde is an
2 6
animal carcinogen.   Horton found no tumors of the lung
after exposing mice to levels of formaldehyde ranging from
40.0 to 700.0 ppm for three hours per week for up to thirty-
27
five weeks.
Current epidemiologic studies provide little evidence of
increased risk of nasal cancer from formaldehyde exposure
but do indicate excesses of leukemia and cancers of the
28
brain and mouth.   Further studies are underway although
most epidemiologic studies are not yet completed.  OSHA
believes that overall cancer mortality is not an appropriate
29
evaluation to determine causal relationships.
Gofmekler observed an increase of pregnancy in rats by
approximately 15.0%, a decrease in lung and liver weight in
offspring, and increased weights of the thymus, heart,
11
kidneys, and adrenals upon exposing pregnant mice to 0.8 and
0.01 ppm formaldehyde.  The most marked changes were in the
30
kidney.   After review of a report by Olsen and Dossing and
a report by Shumilina, OSHA stated that there appeared to be
little, if any, risk of reproductive or teratogenic effects
from the levels of exposure to formaldehyde typical of the
31
occupational environment.
Other biological effects have been noticed in animal
research.  Korean studies have indicated increased arthritis
in rabbits upon intra-articular injections of formalde-
32
hyde.   In male mice chronic exposure to formaldehyde is
associated with liver cytoplasmic vacuolar change and
testicular degeneration.
E.  Throughout the years both the increased use of
formaldehyde and awareness of potential health effects have
brought about changes in the standard for permissible
exposure.  The changes made in the OSHA standard reflect the
experimental evidence showing formaldehyde first as a
cytoplasmic poison causing irritation and dermal effects,
later a systemic poison causing sensitization, and most
recently a carcinogen causing nasal cancer in rats.
In 1943, Henderson and Haggard suggested an airborne
. . 33
exposure limit for formaldehyde of 20.0 ppm.   In 1946, the
ACGIH set a 10.0 ppm threshold limit value (TLV) for
formaldehyde which was lowered to 5.0 ppm in 1948.  The
12
ACGIH later set a 5.0 ppm ceiling limit in 1963, not to be
exceeded at any time.  OSHA adopted a 3.0 ppm eight hour
time weighted average (TWA) and a 5.0 ppm ceiling limit in
1971 based on 1967 American National Standards Institute
(ANSI) standards.  In 1973, the ACGIH lowered their
recommended ceiling limit to 2.0 ppm and as early as 1983
recommended a 1.0 ppm eight hour TWA TLV.
F.  The new OSHA formaldehyde standard which became
effective February 2, 1988 is due in large part to the
evidence of its carcinogenicity.  The latest standard is 1.0
ppm eight hour TWA permissible exposure level (PEL), 2.0 ppm
fifteen minute short term exposure level (STEL), and a 0.5
ppm eight hour TWA action level (AL)."^''' The peak allowable
exposure of 10.0 ppm for no more than thirty minutes was
revoked.
The new standard carried with it a six month compliance
period meaning that by August 2, 1988 exposure
determination, medical surveillance, and emergency
procedures must be completed. The deadline for laboratories
34
was extended until September 2, 1988.
III.  OBJECTIVES
This study was conducted to demonstrate how a modern
medical center could meet the requirements for compliance of
OSHA standards in a way that might serve as a model for
other medical centers.  An additional objective was to
compare some of the formaldehyde sampling methods available
and make recommendations for continued and routine sampling.
The first objective was to plan a comprehensive survey
of formaldehyde users at the medical center.  A complete and
thorough survey is necessary before planning a sampling
strategy.
IV.  PERFORMING THE SURVEY
A.  Because of formaldehyde's widespread and often sporadic
use, developing a sampling strategy at a medical center can
be difficult.  There are many small unrelated departments
using formalin in their own unique way.  Accomplishing an
adequate survey was critical in developing a good strategy.
The survey started by determining the distribution of
formaldehyde within the medical center.  By finding out from
purchasing who is buying formaldehyde in any form, one can
determine who is using it.  In the case of this medical
center, the Central Pharmacy Department makes up 10.0%
buffered formalin from 37.0% formaldehyde and packages it in
one gallon containers. A lot of one hundred to two hundred
one gallon containers is periodically brought to the
Materials Management Department where it is distributed to
the departments that use it.  Obtaining a list from
Materials Management of departments that had checked out the
formalin in the past six months helped identify users. An
example of this list can be found in Appendix Number One.
This list, along with information from purchasing as to
persons buying 37.0% formaldehyde or paraformaldehyde, gave
a starting point to help locate users of formaldehyde.
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With this information, contact was made by phone with
each person or department on each list.  Information was
gathered and recorded to further determine formaldehyde
usage.  Information included what formaldehyde was being
used for, how much (quantity/time), how often, how long
during the day, how it was used (laboratory conditions,
hoods, personal protective equipment), what the current
status was, who was responsible for use, location of use
(building, laboratory number), and a contact name and phone
numbers.  An example of the table used to gather this
information appears in Appendix Number Two.
It was determined from this information that
formaldehyde use was widespread, sometimes heavy, but more
often sporadic and minimal.
B.  With the usage information in hand, a walk-through
survey was conducted.  Each area using formaldehyde was
visited for inspection and to obtain further information
from the employees and supervisor of that area. The number
of people in that area and laboratory conditions were noted
and possible sample scheduling or further contact was
established.
Screening was then done in the heavy use areas by taking
35
grab samples using National Draeger detection tubes.   The
grab sample results gave an idea of exposure concentrations
in these areas and helped determine how much further
sampling was needed. These results are listed in Table 1.
16
Table 1








South Path. Lab (M324) <0.5 General
South Hist. Lab (M329) 6-6 -0.7 1 n
Autopsy Lab (M321) 6-6 <1.0 2 n
Autopsy Storage Room 6-6 1.0-1.4 1 H
Pharmacy Vault 6-6 <0.5 1 M
North Path. Lab (3 544) 6-7 <0.5 3 H
Dial. West 6-7 <0.5 2 N
Dial. Mix Room 6-7 -1.5 1 Dilution
Dial. Main Room 6-7 -0.7 1 General
North Dial. (9224) 6-8 -1.0 1 N
South Hist. Lab (M329) 6-8 -1.0 1 N
Dial. Main Room 6-8 <0.2 2 N
Dial. Home Train Room 6-8 <0.2 1 n
South Hist. Lab 6-8 -0.5 2 Dumping
Jones Lab #249 6-16 0.0 1 BSC Decon.
Dial. Mix Room 6-20 0.5-1.0 3 Dilution
Dial. West 6-21 0.0-0.5 3 N





Care must be taken in using these results, as Balmat
found that monitoring for formaldehyde with the Draeger tube
3 6
can produce excessively high results.   Another study
indicated the same problem at low and high levels of
37
humidity and temperature.   However, to err on the high
side is acceptable when using the tube as a screening device
and the information obtained is still very useful in that
context.
A master's report submitted to the faculty of the
University of North Carolina by Jolley showed that the
Draeger tube can also be used to measure peak exposures
38
during formaldehyde use.   Jolley also used the Miran-IA
Ambient Air Analyzer to measure peak exposures.  The Miran
can also be used as a pre-sample screening device in areas
of high formaldehyde usage.
C.  The first step in planning a strategy is knowing your
resources.  Becoming familiar with your work area,
colleagues, and what is available to you is essential.  The
most critical issue is of course your budget, as most of
your plans revolve around what can or cannot be afforded.
Although a good study will have no financial boundaries,
this is not always the case.
With the usage information and the screening results,
where and when to sample was then determined.  OSHA states
that to protect the health of employees, exposure
18
measurements must be unbiased and representative of employee
39
exposure.   A well designed sampling strategy showing that
all employees are exposed below the PEL with a 95.0%
certainty is sufficient evidence that the exposure limits
are being met, provided approved analytical methods are used
39
for measurements.
There is no best measurement strategy for all
situations.  Some elements to consider when developing a
strategy include the availability and cost of sampling
equipment and analytical facilities, location and work
operations of employees, intraday and interday variations in
the process, number of samples needed, and precision and
accuracy of sampling and analytical methods.  Systematic
changes in the exposure of an employee to formaldehyde can
be caused by the employee changing patterns of movement in
the workplace, closing or opening doors and windows,
ventilation changes from season to season, changes in
production processes or work habits of employees, and
decreases in ventilation efficiency or failure of
engineering controls.
It was decided for this study to immediately and
periodically sample the heaviest users.  Areas such as
Autopsy, Surgical Pathology, and Dialysis were sampled much
more frequently than others because of their heavy usage.
The number of people exposed to formaldehyde in their work
practices determined how many samples were taken in each
19
area.  Smaller use areas that had similar work practices
were included together.  Worst case scenarios were then
determined and sampled.  Areas were broken down into heavy,
moderate, and low use by frequency or volume of use (Table
2).  Type of use was then described for each category.
Table 2A shows how each area was classified as to type of
use.
Area samples may not be representative of employee
exposure.  Personal samples better describe actual employee
exposure and should be used to document them.  However, area
samples were taken in some cases to assess general room
concentrations, to determine migration of formaldehyde into
nearby areas, and in one specific area where formaldehyde
exposure occurs but is used by more than one person.  If
there was an area where formaldehyde was used sporadically
throughout the day by a number of employees entering and
leaving that area, it was assumed that if the formaldehyde
concentration was below the action level in that area and
any one person working in that area would not be exposed
over the action level.
OSHA states that if employees may be exposed above the
action level, the employer must measure the exposure.  In
this study exposure was measured initially and if the
exposure was above the action level, further sampling was
done.  If exposure was above the PEL, recommendations were
made to lower exposure and subsequent sampling was done.
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Table 2
Formaldehyde Concentrations by Usage
Area Type of Use Aver aere PPM
Heavy Usacre
Autopsy Lab Tissue Preservation 0.12
Path./HiSt. Lab II       II 0.29
Pharmacy Dilution 0.10
Autopsy Lab II 0.19
Dialysis II 1.84






















Heart,Lung, & Blood Inst,
Anat. Div. of OBGYN
Micro./Imm. Lab #316
II












Classification by Type of Use
Tissue Preservation Di lution SteriIi zat i on/Decontami lation
Autopsy Lab 8 Central Pharmacy 8 Bio. Safety Cabinet 6
Pathology Lab 7 Autopsy Lab 7 Dialysis Main 4
Histology Lab 4 Dialysis Main 5 Dialysis North 3
Dept. of Surgery Lab #125 3 Dial. North/West 3 Dialysis West 2
Neuropathology 3 Vivarium 2 Surgical Diag. Clinic 0.5
Vivarium 2 VA Pathology Lab 1 Surgical Out-Patient 0.5
Heart, Lung, Blood Inst. 2 Micro/Imm Dept (3) 1
Delivery Room 1 Perfusions Northern Blot Gels
VA Pathology Lab 1
Hyperbaric Clin Program 1 Hyperbaric Clin Prog 2 Micro/Imm Dept Lab #316 3
Rheum/Imm Lab #369 Carl 0 .5 Dept. Med. Lab #350 2 Lab #311 2
Div. Neurosurgery (Busse) 0 .5 Div of Neurosurgery 1 Lab #350 2
Emergency Department 0 .5 Dept of Micro/Imm 1 Lab #328 1
Surgical Diag. Clinic 0 .2 Anatomy Div of OBGYN 1 Dept of Med/Neur. Div.
RP #1 1
Surgical Out-Patient Clin 0.2 "       RP #3 1
Blood Tray Prep.
Dept of Micro/Imm RP #3
VA Pathology Lab
Reagent Prep.
Chemistry lab #341 0.5
Biopsy Specimens
Pap Smears
Dept of Med Endoscopy  4   Allergy & Pulmonary Clin 2
Allgy & Pulm. Clinic  2  Emergency Dept.        1
Surgical Diag. Clinic  1
Use Scale*
Lou   1
Moderate
10 Heavy
* Compared within type of use
V.  SAMPLING AND ANALYSIS
A.  Accurate and precise measurements of formaldehyde in the
workplace is becoming more important as the health effects
are better understood.  Formaldehyde sampling methods are
numerous, varied, and still being researched and refined.
One of the earliest methods for collection and analysis of
40
formaldehyde m air was published in 1943.   Growing
concern of the potential adverse health effects associated
with formaldehyde has generated renewed interest in sampling
and analytical methods.  Table 3 lists the methods available
for formaldehyde sampling and analysis.  Table 4 shows some
operational parameters and Table 5 lists some advantages,
disadvantages, and limitations.
The best known and most sensitive collection method is
the impinger with solution.  Many different solutions can be
used in the impinger to collect formaldehyde vapor including
Girard T Reagent, distilled water, 3.0% hydrogen peroxide in
0.025 N sodium hydroxide, and 2,4 dinitro-phenylhydrazine
(DNPH) plus perchloric acid.  The most common solution and
the one suggested in the National Institute of Occupational
Safety and Health (NIOSH) method 3500 is 1.0% sodium
bisulfite.   This NIOSH method 3500 was originally adapted














Collect in impinger with distilled water; add 1% chromotropic
acid (CTA) followed by concentrated sulfuric acid; meanuro
spectrophotometrically at 580 nm.
Collect on alumina sorbent; desorb immediately into 1% solution
of methanol in water; determine formaldehyde by CTA method.
Formaldehyde collected in sodium bisulfite solution in pnBnive
sampling badge; formaldehyde in solution determined by CTA method
(Dupont).
Formaldehyde collected on bisulfite-impregnated pad in passive
sampling badge; formaldehyde-bisulfite adduct oluted with v;nter;
formaldehyde determined by CTA method (3M).
Formaldehyde collected in water in an impinger; mix with solution
of tetrachloromercurate II plus sodium sulfate; add





Formaldehyde collected in impinger with deionized water; add
acidified pararosaniline followed by sodium sulfite; measure
spectrophotometrically at 570 nm.
Formaldehyde collected on 13 X molecular sieve, desorbed with
deionized water; formaldehyde determined by PR method.
Formaldehyde collected in bubblers containing DNPH in
hydrochloric acid, which react to form insoluble precipitate;
dissolve filtered precipitate in acetonitrile and measure, using
high performance liquid chromatography with UV detection.
Formaldehyde collected in impingers containing 2,4-DNPII plus
perchloric acid (catalyst); measure hydrazone formed using IIPLC









Govt No. Analytical Scheme
Collect formaldehyde on silica gel coated with DNPH; desorb with
acetonitrile; measure with HPLC with UV detection.
Formaldehyde collected on XAD-2 resin coated with 2,4 DNPH;
hydrazone eluted with ethyl ether and measured using gas
chromatography with flame ionization detection.
Formaldehyde collected on filter paper, silica gel, or in
impinger coated with/containing MDTH; add ferric chloride to form











Collect formaldehyde in bubbler containing MBTH; add ferric
chloride and sulfamic acid to form blue cationic dye; measure
spectrophotometrically at 628 nm.
NIOSII    Collect formaldehyde in impinger with Girard T reagent; measure
S327     formaldehyde-Girard T reagent derivative by polarography.
Collect formaldehyde in bubbler using 10% methanol in water;
react solution with hydrazine (H2NNH2) to form formaldehyde-
hydrazone; measure derivative by differential pulse polarography.
NIOSH    Collect formaldehyde on charcoal impregnated with oxidizing
318      agent; desorb in 0.1% hydrogen peroxide solution; measure formate
ion by ion chromatography.
NIOSH    Collect formaldehyde on charcoal impregnated with BAE; the
354      benzloxazolidine formed is desorbed with isooctane and measured
using capillary-column gas chromatography with flame ionization
detection.
2-HMP OSHA 52  Formaldehyde in air drawn through XAD-2 sorbent coated with 2-
(hydroxymethyl) piperidine to form oxazolidine; oxazolidine
desorbed with toluene and measured using packed column gas









Govt No. Analytical Scheme
Collect formaldehyde in impingers containing 3% hydrogen peroxidein 0.025 N sodium liydroxide; measure formate ion formed using ion
chromatography.
Collect formaldehyde in impingers containing 0.025  M pH 7phosphate buffer plus ~10""^ M EDTA; excess bisulfite^is added
the collected samples to form the 1:1 formaldehyde bisulfite
adduct; the excess bisulfite is reacted with DTHB to form a
product measured spectrophotometrically at 412 nm; the amount
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bubbler 0.1-0.2 18 6.0 0.25
bubbler 0.7-1.2 30 1.0 0.008
coated charcoal 0.2 100 3.0 0.02
XAD-2 coated 0.08 38 2.0 0.04
XAD-2 coated 0.1 24 0.48 0.013
impinger 0.5 30 2.0 0.05
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TABLE 5".   Advantages, Disadvantages, and Liabilities of Available Methods*
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from the Intersociety Committee and designated P + CAM
42    .        .     . . ,  .
125.    This method is considered "active" because air is
drawn through the impinger at a known flow rate by a
calibrated sampling pump.
Alternatives to the impinger sampling method have been
sought due to the awkwardness of wearing an impinger and the
likelihood of liquid spillage or breakage of the glass
impinger.  There are also more interferences with the
impinger method by such chemicals or air contaminants as
phenols, alcohols, and olefins.
Another active method is drawing air at a known flow
rate through a sorbent tube.  Many different sorbents have
been used, most coated or impregnated with specific
compounds.  Since charcoal alone as a sorbent was found to
be ineffective due to low recovery, many different sorbents
have been tried and are still being developed.  Some of
these sorbents include alumina, 13X activated molecular
sieves, silica gel or XAD-2 resin coated with 2,4 DNPH, and
XAD-2 coated with 2-(hydroxymethyl)piperidine.  The sorbent
suggested by NIOSH method 2502 (P+ CAM 354) is chromosorb
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102 or XAD-2 coated with 2-(ben2ylamino)ethanol.   These
tubes are available commercially as Supelco ORBO-22 sorbent
tubes.  A new tube has just been developed and tested and
consists of silica gel impregnated with 20.0% sodium
bisulfite.'**
Another alternative to both impinger sampling and active
sampling in general is known as passive or diffusive
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monitoring.  This method is by far the easiest and simplest
to use but can have many limitations.
This method consists of using a passive sampling badge
that does not draw air in actively but by diffusion.  The
badge is less cumbersome to wear for the employee and can be
used in area sampling for longer periods of time over
several work shifts if needed.  It is lightweight, compact,
and less restrictive.  It is simply clipped to the
employee's collar or set in an area where there is
sufficient air movement.  If the badge is put in an area
without sufficient air movement or where the air is
stagnant, diffusion may be inefficient causing inaccurate
monitoring.  Other limitations include extreme temperatures,
extreme relative humidities, shelf life, post-use storage
capabilities, and inability to use for short term fifteen
minute exposures.
Different types of commercially available badges include
the DuPont Series II type C-60, 3M 3720 and 3721, Kem
Medical Vapor-trak, and the Air Quality Research PF-20.  The
DuPont C-60 badge contains a sodium bisulfite solution and
the 3M, Kem Medical, and Air Quality Research badges all use
a bisulfite impregnated pad.  Each badge type has its own
advantages and limitations and should be carefully reviewed
before choosing a particular badge.
A wide variety of analytical methods are available for
measurement of sampled formaldehyde. Table 3 shows the
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corresponding analysis technique for each sampling
methodology while Table 4 lists some operational parameters.
Because of formaldehyde's instability and reactivity,
analytical methods do not involve direct measurement of the
foirmaldehyde.  A product of a reaction between formaldehyde
and another chemical is measured instead.
The most common analytical procedures are the
chromotropic acid (CTA) and pararosaniline methods.  Both
methods consist of a formation of colored products that can
be measured using a spectrophotometer.  The CTA method forms
a purple monocationic chromogen upon addition of
chromotropic acid and sulfuric acid to a two to four
milliliter aliquot of the formaldehyde sample. The
absorbance of the colored solution is read in a
spectrophotometer at 580.0 nanometers and is proportional to
the amount of formaldehyde in the solution.  Impinger
samples and all diffusive monitors are analyzed using the
CTA method.  Some sorbent tubes are analyzed in this way,
such as an alumina sorbent and the new silica gel
impregnated with 20.0% sodium bisulfite tube.  The CTA
method is described in the NIOSH 3500 method.
Another analytical procedure is gas chromatography with
a packed column and nitrogen-phosphorus flame ionization
detector (FID).  This procedure is used for the commercial
45
XAD-2 tubes (Supelco ORBO-22) and is outlined by OSHA 52
and the NIOSH 2502"^"^ methods.  Other analytical procedures
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include liquid chromatography with ultra-violet detection,
ion chromatography, and polarography.
B.  Part of the sampling strategy is choosing the
appropriate sampling equipment and means of analysis.
Equipment was chosen based on accuracy, reproducibility,
cost, availability, ease of use, and how quickly results
could be obtained.  Extensive literature research was
conducted in order to learn more about each method's
procedures, effectiveness, and limitations.  Table 5 lists
some of these limitations which should be considered before
choosing which method to use.
Several different methods were used for comparison
purposes and to establish a reliable, cost efficient means
of sampling following this study.  Two active methods were
used, the impinger with 20.0 ml of 1.0% sodium bisulfite
solution and a Supelco ORBO-22 sorbent tube.  The impinger
method was used for short term personal sampling, from
fifteen minutes to one hour, and for long term (eight hour
TWA) area samples.  It was chosen because it is the most
sensitive method, everything needed was readily available,
and because analysis could be done immediately in-house
using a spectrophotometer.
The Supelco ORBO-22 sorbent tube was used for long term
personal and area sampling.  It was chosen because it is
less awkward for an employee to wear all day than the
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impinger and because it was originally planned to be
analyzed in-house, using an available gas chromatograph.  It
was later decided that in-house analysis would be too
difficult and time consuming, therefore the tubes were sent
to an accredited laboratory for analysis.
A third active method using 13X activated molecular
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Sieves, suggested by Gold  and a master's report submitted
to the faculty of the University of North Carolina by
47    ...
Hoffner,  was initially tried.  Their work showed that the
13X molecular sieves could be used to efficiently collect
formaldehyde.  This method could be used at very little cost
because the tubes could be prepared by the person doing the
sampling and analysis could be done in-house using the
spectrophotometer.  This method was abandoned due to poor
results and time restraints, but should still be considered
in the future for formaldehyde sampling.
Six different kinds of passive monitors were used during
this study.  Monitors that were already in the Environmental
Safety Department and those that were sent as free samples
were used until a decision was made as to which fit our
needs.  The monitors used were the DuPont Series II type C-
60, 3M3720, 3M3721, Kem Medical Vapor-trak, Air Quality
Research PF-20, and the Bacharach Air-Scan.  The DuPont C-60
and 3M 3721 could be analyzed in-house using the CTA method
and the spectrophotometer.  The 3M 3720, Kem Medical Vapor-
trak, and Air Quality Research PF-20 were all sent back to
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the manufacturer for analysis.  The Bacharach monitor was
analyzed immediately after use and gave results within eight
to ten minutes by a staining method.
The Air Quality Research PF-20 and Bacharach Air-Scan
monitors were both used only on two separate occasions.  The
PF-20's use was discontinued due to cost and turn around
time for results.  The Bacharach was no longer used because
of cost, difficulty with analysis, and sample results.
The Kem Medical Vapor-trak was used throughout the study
for fifteen minute short term sampling and long term
personal and area sampling. The Vapor-trak is the only
diffusive monitor recommended for short term sampling and
was used with and later in place of the impinger.
Both the DuPont C-60 and the 3M 3720 were used initially
for long term personal and area sampling.  A field study
done by Kennedy and Hull compared the two methods for
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performance and reliability.   The DuPont C-60 was
eventually chosen over the 3M 3720 because both the monitors
and the sample results could be obtained more quickly.  The
3M 3720 and 3721 were later compared but were discarded
because of poor results and slow delivery of the badges.
Table 6 shows what methods were used for each situation.
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Table 6





ORBO-22 Sorbent Tube, DuPont C-60
Badge, Kem Medical Badge, 3M 3720/
3721 Badge, Air Quality Research
PF-20, Bacharach Air-Scan
Impinger with 1.0% NaHSO., ORBO-22
tube, 13X Molecular Sieves, DuPont C-
60 Badge, 3M 3720/3721 Badge, Kem
Medical Badge
Short Term Personal Impinger with 1.0% NaHSO,, Kem
Medical Badge
Instantaneous Grab National Draeger Coloration Tube
VI.  RESULTS
A brief discussion is given for each area as to how
formaldehyde is used, how often, how many people use it, and
conditions or handling procedures that existed. Results are
then listed for air sampling done in that area.  Heavy use
areas are discussed first, followed by moderate and finally
low use areas.  Table 2A shows the types of use and areas
that use formaldehyde in that way.  All employees were
notified of the sampling results using the form found in
Appendix Number 3.
A.  The largest and most widespread use of fonaaldehyde was
found to be for tissue preservation or fixation.  It
includes the heaviest users of formaldehyde in Autopsy and
Surgical Pathology.  In most cases a 10.0% formalin solution
was used to preserve animal parts or human tissue for later
examination and experimentation.
The Autopsy Laboratory can be one of the largest users
of formalin at a medical center.  Whenever an autopsy is
performed, all tissue removed from the body is placed in a
container with formalin for later gross examination.  The
brain is removed and stored in a ten quart pot with
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formalin.  Autopsies are performed on unpreserved bodies
received directly from the hospital.  The bodies are kept
refrigerated if an autopsy cannot be performed immediately
after death.
This medical center's Autopsy Lab has four technicians
working in it.  Two of the four assist in autopsies, one is
responsible for formaldehyde dilution and occasional pot
dumping, and the fourth is a "runner" who transports bodies
and does general office work.  Both area samples and
personal samples on the technicians were collected.
Formaldehyde exposures can occur in three different
ways.  The first is when a technician is in the laboratory
assisting with an autopsy.  The technician is responsible
for laying out instruments, preparing the body, filling pots
and containers with formalin, and transferring the formalin
containers between the autopsy table and storage. Autopsies
are not done everyday and normally there are no more than
one or two in a day.  There may be occasions when more than
two are done in a day, but it is a rare occurrence.
A second source of potential exposure in Autopsy is when
formaldehyde is diluted to 10.0% formalin.  This will be
discussed in detail later with the other dilution
procedures.
The third potential source of exposure in Autopsy is
when pots containing brains in formalin are periodically
dumped. Anywhere from ten to twenty pots are normally
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dumped approximately every six to twelve weeks.  The
formalin in the pots is poured down a sink under the exhaust
hood in the Autopsy Laboratory and normally takes
approximately thirty minutes to complete.  The brains are
then put in a plastic bag and later burned in an
incinerator.  The technician wears gloves and an apron
during the dumping procedure.  All sample results are well
below the OSHA PEL and STEL.  All areas where formaldehyde
exposure can occur were well ventilated.  Routine sampling
is suggested due to the high formaldehyde use.  These
results are summarized in Table 7.
Another heavy user of formalin for preserving tissue is
the Surgical Pathology Laboratory.  This laboratory receives
specimens from surgery or from areas doing biopsies in
containers with 10.0% formalin.  The containers are kept on
a storage shelf in the laboratory for further examination.
There are two tissue specimen sectioning rooms where
pathology residents examine and describe these specimens.
Each of these rooms is small (approximately 7.5 feet by 7.5
feet) and has a cutting area with local exhaust ventilation
where the resident works. The resident removes the
specimens from the container, cuts and examines it while
dictating, and places it in a small (approximately 1/2 inch
X 1 1/2 inches) perforated plastic container called a "tim".
The tims are then placed in a one gallon plastic container
containing 10.0% formalin.  The formalin is later poured
Table 7
Autopsy Laboratory Sample Results
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Sample
Sample # Date Method Time (rains.)
88-A09 6-28 Impinger 438
88-A10 II ORBO-22 438
88-A11 II 13X Sieve 438
88-A12 II 3M 3720 435
88-A13 11 DuP C-60 437
88-A14 II Vapor-trak 436
88-67 9-1 Vapor-trak 33
88-69 9-1 II 15
88-71 9-20 II 30
88-35 8-8 DuP C-60 466
88-44 8-11 Vapor-trak 393
88-54 8-18 DuP C-60 452
PPH Comments
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off, replaced with water, and the tims are brought to the
Histology Laboratory for processing and further examination.
Normally two or three doctors worked in a room during an
eight hour period, therefore area sampling was done in each
room near the cutting area to determine exposure.
Although many people worked in the Pathology Laboratory,
only one technician had the potential for exposure.  The
technician is responsible for checking in each specimen
container (with opportunity to open it), keeping a five
gallon jug of formalin filled in each sectioning room,
setting up containers in sectioning rooms for residents to
work with, pouring off the formalin in the container that
residents place tims in, and transporting tims to Histology.
Personal samples were taken of this technician on several
different days.  The results of these samples and of the
area sections room samples are shown in Table 8. All
samples results were well below the OSHA PEL, showing
adequate local exhaust ventilation in the sections room and
good work practices by the technician.
Smaller laboratories that are a part of the Surgical
Pathology Department include Histology and Neuropathology.
Formalin use in each of these laboratories is minimal.  They
each receive specimens for preparation and examination on a
smaller scale than the Pathology laboratory.
The Histology Laboratory has two potential sources of
exposure.  Each operation is short term and has one
Table 8
Pathology Laboratory Sample Results
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Area   Sample #  Date   Method




88-A26 II ORBO-22 11
88-A27 II 3M 3720 II
88-A28 II 3M 3721 II
88-A35 8-18 ORBO-22 484
88-A36 II DuP C-60 M
88-A42 9-1 Vapor-trak 300
88-16 7-14 ORBO-22 505
88-17 II 3M 3720 500
88-18 II AQRPF-20 501
88-49 8-16 ORBO-22 480
88-50 II DuP C-60 II
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technician responsible for it.  The first procedure consists
of loading specimens into tims and putting tims into a metal
basket to be processed.  Some specimens are taken out of
pint containers with formalin, rinsed with water, and put in
tims.  Most of the tims are already filled with specimens
and have been rinsed.  This procedure is done at a sink in a
back room of the Histology Laboratory.  It normally takes
ten to twenty minutes to complete and is done at the end of
every working day.  It used to be done on a larger scale
three times a week after the first workshift but was
discontinued midway through this study.  Fifteen minute
short term personal samples were taken during this
procedure.
The second source of exposure was found to be during the
dumping of formalin from one gallon jugs.  Every Monday,
Wednesday, and Friday three or four one gallon jugs are
removed from the processor and dumped along with two one
gallon water jugs and ten to fourteen one gallon jugs of
alcohol.  This is done in a sink in the corner of the main
Histology Laboratory.  The dumping takes fifteen to twenty
minutes, including re-filling all formalin, alcohol, and
water jugs.  The technician wears rubber gloves and an apron
while performing this operation.
The first fifteen minute short term personal sample
taken was found to be above the OSHA STEL (88-48).  A second
sample was below the STEL but still above the action level
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(88-65).  During the dumping, the water tap was left running
the entire time.  A similar high result was found in the
Dialysis unit (discussed later in Section C) when pouring
formalin in a sink while tap water was running.  It was
therefore thought that the running water was creating
turbulence and causing formaldehyde vapor to be brought up
from the sink to the worker's breathing zone.  Two
subsequent samples were taken on separate occasions.  The
technician was asked to dump the formalin first without the
tap water running.  In both cases the exposure was greatly
reduced, both being below the detection limit of the
sampling device (88-73, 88-82).
In the Neuropathology Laboratory, there are three
different people who can have minimal exposure to
formaldehyde.  One potential source of exposure is loading
tims in a basket to be processed.  All tims with specimens
have been rinsed with water before arriving in the
laboratory.  The specimen containers are kept under an
exhaust hood and any specimen removal or pouring off of
formaldehyde from these containers is done at the sink in
the laboratory.
Another source of exposure includes making up slides by
putting one or two drops of 20.0% formaldehyde on them.
These slides are made up almost every day but only a couple
of times in a day. Exposure can also come from making up
five gallons of 2 0.0% formaldehyde approximately once a
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month or making four liters of Elvers fixative approximately
every six to eight weeks.  Elvers fixative includes
formalin, glycerin, acetic acid, and alcohol.
Another procedure in the Neuropathology Department that
is a potential source of exposure is brain cutting.  Every
Wednesday at four o'clock a doctor cuts and examines a
number of brains while eight to twelve Pathology residents
surrounding him make observations. Each brain takes
approximately fifteen minutes to cut and normally one to
four are processed.  The brains have been sitting in 10.0%
formalin for a period of time but are normally rinsed with
water and placed in a container with water before cutting.
This is done in a classroom on a cart with no local exhaust
ventilation.  The doctor wears gloves and an apron.
The sample results for both Histology and Neuropathology
are summarized in Table 9.  Except for the dumping procedure
in the histology laboratory discussed earlier, all samples
taken were below the OSHA PEL and STEL.
There are four areas that use formaldehyde for specimen
preservation during biopsies.  These are the Endoscopy
Laboratory, the Allergy and Pulmonary Clinic, the Surgical
Diagnostic Clinic, and the OBGYN Clinic.  All four use
formalin to preserve specimens as they are removed from a
patient during a biopsy. A pint container of formalin is
kept on hand and opened long enough to drop the specimen in.
Biopsies are done on a particular day, but it is never known
Table 9
Histology and Neuropathology Sample Results
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Area   Sample #  Date    Method
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whether a specimen will be taken until the biopsy is done.
Generally two to six biopsies are done in a day, therefore
the container could be opened six times during the course of
a day for a total of less than thirty minutes.
Of the four units, the Endoscopy Laboratory has more
opportunity to use the formalin.  There is normally more
than one nurse who assists in the biopsies, therefore area
samples were taken near the formalin container to determine
exposure.  An area sample was set up in the proctoscopy room
of the Surgical Diagnostic Clinic due to more than one
person assisting on the biopsies.  Personal samples were
also taken in the Endoscopy Laboratory and the Allergy and
Pulmonary Clinic when only one person assisted with
biopsies.  All results were below the OSHA PEL and are given
in Table 10.
There are three areas that use formaldehyde to preserve
specimens in after surgery. They are the Emergency
Department, the Delivery Room, and the VA Medical Center
Pathology Laboratory.  Each uses formaldehyde very
sporadically and has limited potential exposure.
In the Emergency Room, formalin is used to drop moles or
lesions in that have been removed from a patient.  The
greatest use of formalin in the Emergency Room is for
preserving aborted fetuses.  The fetus is put in an
appropriate container according to its size.  The assisting
nurse will fill the container with 10.0% formalin to be sent
Table 10
Sample Results from Areas Performing Biopsies
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Area   Sample #  Date Method
Endoscopy 88-A15 7-14 Impinger
Lab
88-A16     " 3M 3720
"    88-A17    " DuP C-60
"    88-A18    " ORBO-22
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All.+Pulm. = Allergy and Pulmonary Clinic
S.D.C. = Surgical Diagnostic Clinic
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later to the Surgical Pathology Laboratory.  This may be
done once or twice a week as needed.
In the Delivery Room, specimens are put in containers
with 10.0% formalin when doing bilateral tubal ligations or
performing C-sections on patients.  Each may be done two or
three times in a day with the containers being opened for
just a few seconds to drop specimens in.  Both operations
are emergency procedures, therefore use of formalin is
unpredictable.
The VA Pathology Laboratory uses formalin even more
sporadically, only once or twice in a day once a week.
Specimens are put in containers with formalin and are
brought to the medical center's Pathology Laboratory.
No samples were taken in any of these three laboratories
due to the sporadic and unpredictable use.  The potential
exposure was assumed to be represented by other areas that
use formaldehyde in a similar way more frequently.
Animal research is very prevalent in a medical research
facility. Many different animals are used, including pigs,
monkeys, dogs, rabbits, and mostly mice and rats.  While the
volume of formaldehyde used does not approach that used by
the Autopsy or Pathology Laboratories, the number of
laboratories conducting animal experimentation is greater
and the use is more widespread.  Nine different laboratories
were found during this study that used some form of
formaldehyde for animal research and experimentation.
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There are five laboratories that use formalin during
animal surgery to store specimens. There are generally one
to four people performing surgery in each laboratory and it
may be done anywhere from two or three times a week to once
every two or three months.  The containers are opened just
long enough to introduce specimens in.  In a one to two hour
surgery the container might be opened for a total of ten to
fifteen minutes.
The Institute of Allergy Infectious Diseases in the
Department of Surgery does surgery one or two times in a
week.  It is done on a table by one of three people with no
local exhaust ventilation.  They also transfer these
specimens from test tubes to tims approximately once a
month.  The transfer is done under a hood and ten to twenty
tubes are typically used taking ten to fifteen minutes.
The Division of Neurosurgery, the Rheumatology and
Immunology Research Laboratory, and the Vivarium all perform
animal surgery under a hood once every two to three months.
The Vivarium performs rat necropsies on a larger scale than
the other two laboratories, but none of the three did any
surgery during the time of this study so no sampling was
done.
The Heart, Lung, and Blood Institute is the fifth
laboratory using formaldehyde for animal research.  One of
two people periodically removed rat hearts from containers
with formalin to cut them into smaller pieces and take
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photographs.  This was done every two to three weeks on a
table and generally took three to six hours to complete,
depending on the number of hearts.  The hearts were rinsed
with tap water at "a sink after removing from the formalin
and before cutting.
There are also four other laboratories and one mentioned
previously that use some type of formaldehyde for animal
perfusions.  Two of these laboratories, the Hyperbaric
Clinical Program and the Anatomy Division of the OBGYN
Department, use liquid formalin for perfusion during animal
surgery.  Each one has the formalin run into a cavity inside
the animal for ten to fifteen minutes during the surgery.
One person is responsible for the surgery and it is done as
needed on a workbench without local exhaust ventilation.  It
is normally months between perfusions and is very
unpredictable.
The Division of Neurosurgery mentioned previously, the
Division of Allergy Clinical Care of the Department of
Medicine, and one laboratory of the Department of
Microbiology and Immunology also do animal perfusions.  Each
of these three laboratories use paraformaldehyde when doing
animal surgery once every two to three months.  One person
is responsible for heating and dissolving approximately ten
grams of paraformaldehyde in fifty to one hundred
milliliters of water or gluteraldehyde solution under a
hood.  The solution is then used for perfusion during
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surgery or electromicroscopy of animals.  This is also done
under a hood.  The fixative solution generally runs for ten
to fifteen minutes during a one to two hour operation.
All nine laboratories use formaldehyde for tissue
preservation or fixation during animal research
sporadically, in small quantities, and the operators are
generally well protected. Exposures to formaldehyde in any
of these laboratories was believed to be minimal.  Sampling
could not be scheduled due to the unpredictable use,
therefore sampling was sporadic and minimal.  The results of
sampling done in all of the nine laboratories are shown in
Table 11.
B.  Using formaldehyde for sterilization and decontamination
in a hospital setting can be traced back one hundred years
5
ago.  Along with heat sterilization, it is one of the most
widely used means of inactivating microorganisms.  The
number of different areas that use formaldehyde for these
purposes is not as great as the number that use it for
tissue preservation and fixation, but the number of people
in contact with formaldehyde in these areas and the
potential exposures are greater.
The biggest user of formaldehyde for sterilization
purposes is the Dialysis Laboratory.  At the medical center
there are two units, a Hemodialysis unit in the North
Hospital with eight beds and a larger Dialysis Center off
53
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HLBI = Heart, Lung, and Blood Institute
ADOB = Anatomy Division of the OBGYN
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campus with three sections and twenty-five beds.  Both of
these units use a 5.0% formalin solution to sterilize their
dialysis machines.
In the North Hemodialysis Unit, six technicians are
responsible for taking care of patients and the dialysis
machines.  Typically these patients are on the machines only
during the first eight hour work shift, but occasionally
there is a need for a patient to be on a machine for an
extended period of time.  There is a large room with five
machines and three smaller rooms with one machine in each.
Each machine is sterilized with formalin solution at the
end of each use. One person, usually the head nurse, is
responsible for mixing up seven liters of a 5.0% formalin
solution.  This is done at a sink in a small room and
generally takes five to ten minutes.  This seven liter
container is then used by any one of the six technicians to
sterilize the dialysis machines.  This is done by placing a
vacuum line down into the container.  The machine then sucks
in approximately 150.0 milliliters of the formalin solution,
taking about ten minutes to do so.  The formalin is left in
the machine overnight.  One technician will then come in
early the next day to set up the machines.  The first thing
the technician does is drain the formalin out of the
machine.  The formalin is emptied through a hose-line into a
floor drain.  Splattering may occur here, but the technician
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is generally not near the machine.  The draining process
takes approximately ten minutes and the machine is then
ready for use.  All day personal samples and fifteen minute
short term samples were taken in North Hemodialysis during
dilution.
The Dialysis Center is composed of three separate areas,
all in one building, approximately three miles from the
North Hospital.  All three areas receive patients daily for
six to eight hours and no patients remain overnight.  The
three areas are the main room with seventeen dialysis
machines, Dialysis West with five machines, and the home
training room with three machines.  The main room is the
largest of the three sections (~30 feet by 40 feet) and
typically has eight technicians assigned to it. All
seventeen machines are sterilized daily with 5.0% formalin
solution according to the procedure described for the North
Hemodialysis Unit.
Dialysis West, with an area one-third the size of the
main room, normally has two technicians operating the five
machines.  Four of the five machines are sterilized daily
with 5.0% formalin and one machine is sterilized by sucking
in approximately 1/4 cup of 40.0% formaldehyde solution.
The same sterilization procedure is used for all five
machines.
The home training room also has two technicians who
operate three machines in an area the size of Dialysis West.
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All three of these machines are sterilized using the same
procedure but use 1/4 cup of 40.0% formaldehyde solution
instead of the 5.0% formalin solution.  Toward the end of
this study, the home training room was not being used
regularly but only for overflow from the main room.
One technician is responsible for sterilizing the R/0
water system once a month.  The technician pours one cup of
40.0% formaldehyde solution into the system where it is left
for eight to ten hours.  The formaldehyde is then drained
out into a floor drain.
The other potential formaldehyde exposure is during the
5.0% formalin mixing done every day.  A different technician
each day is responsible for the dilution in the main room
and one technician does the dilution in Dialysis West.  The
dilution and the fifteen minute short term samples taken
during it will be discussed in greater detail later.
All twenty technicians in each of the four areas of
Dialysis rotate between areas.  The technicians have
opportunity to work in either the North Hemodialysis Unit or
in one of the three areas in the Dialysis Center.  Long term
personal and area samples were taken in each area along with
the fifteen minute short term samples.  The number of
samples taken depended on the number of people working in
the area. All long term personal and area samples taken













)     PPM Coninents
Main ORBO-22 <det. limit Area sample
» 88-A23 II 3M 3721 453 0.03 H
H 88-A24 11 3M 3720 II <det. limit II
U 88-31 8-4 DuP C-60 428 0.15 Tech. sartple
H 88-38 8-10 ti 505 <det. limit II
« 88-52 8-17 II 480 0.13 II
, w 88-56 8-24 II 345 0.26 H
M' . 88-66 9-1 Vapor-trak 460 0.04 H
R 88-74 9-22 DuP C-60 450 0.21 ".
North 88-26 7-27 II 463 0.13 U
H 88-47 8-15 II 452 0.17 M
H 88-63 8-31 Vapor-trak 320 <det. limit II
West 88-32 8-4 3M 3721 420 ͣ n
H 88-33 II 3M 3720 420 ͣ ͣ
H 88-39 8-10 DuP C-60 499 0.27 H
H 88-55 8-24 II 350 0.18 U
Main = Main Room of Dialysis Center
North = North Hospital Dialysis Unit
West = Dialysis West
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Two other areas using 10.0% formalin solution for
sterilization purposes are the Surgical Diagnostic Clinic
and the Surgical Out-Patient Clinic.  Each unit uses
formalin to sterilize tools in once a week.  Approximately
1/2 gallon of 40.0% formaldehyde solution is poured into a
basin in a sink.  The tools are soaked for approximately one
hour.  The formaldehyde is then poured down the drain and
the tools are rinsed with water.  The exposure was thought
to be minimal, therefore, no samples were taken.
Formaldehyde is, in general, the chemical of choice for
7   .    .
space disinfection.   Biological safety cabinets,
incubators, refrigerators, laboratory rooms, building, or
other enclosed spaces can be disinfected with formaldehyde.
The opportunity to sample during decontamination of
biological safety cabinets presented itself and will be
discussed.
When biological safety cabinets are used in biomedical
research, a routine performance certification is necessary
when infectious agents have been used in the cabinet.
Before certification can be done, a thorough decontamination
of the cabinet must be achieved to allow the certifier to
enter the cabinet without risk of infection. Decontamination
is done with formaldehyde by heating paraformaldehyde inside
the sealed cabinet to liberate formaldehyde gas.  The gas is
left in the cabinet for two to four hours or in some cases
overnight. After this time a neutralizing agent, usually
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ammonium carbonate, is heated and allowed to mix with the
formaldehyde gas.  The cabinet is then purged slowly and
opened for the certification process.  The certifier can
then enter the confined space of the cabinet to wipe down
the gas residue and to check the cabinet's filters for
leaks.
Formaldehyde exposures were measured during the
decontamination and certification process and at certain
times when peak exposures were expected.  Both personal and
area long-term samples were taken along with fifteen minute
short-term samples during purging.  Personal samples were
taken on the person performing the certification and his
assistant. Area samples were taken in the laboratory area
approximately three feet from the face of the cabinet to
determine possible migration of formaldehyde vapor and to
determine the potential exposure if a person worked in that
area.
All but one of the long term personal and area samples
taken were below the OSHA eight hour TWA PEL.  Two personal
samples were above the OSHA action level of 0.5 ppm (88-01,
88-45).  Personal samples taken on two separate people
working on the same cabinet showed slightly higher results
for the person more involved with the decontamination.
One long term area sample was above the OSHA PEL of 1.0
ppm.  It was taken in a laboratory where the formaldehyde
gas was left in the cabinet overnight, showing a source of
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potential exposure for someone working in that laboratory
during that time.  The area sample taken the next day after
neutralization was considerably lower and below the OSHA
PEL.
None of the fifteen minute samples were above the OSHA
STEL of 2.0 ppm.  One sample did approach the STEL (88-61)
while others were high, showing that peak exposures did
occur during the purging process.  The weighing out and
addition of paraformaldehyde to the heating devices could
provide another source of peak exposures. No fifteen minute
samples were taken during this procedure because the
paraformaldehyde had already been pre-weighed earlier by the
people doing the decontamination.  A summary of results are
shown in Table 13.
From these results it is concluded that as long as care
is taken to properly seal the cabinet and the neutralization
process is done, persons performing the decontamination and
certification of biological safety cabinets have a low
potential health risk from formaldehyde exposure.
Recommendations include wearing gloves when wiping down the
residue inside the cabinet to avoid skin contact, wearing a
respirator when inside the cabinet during certification, and
attaching a flexible hose to the cabinet exhaust vent
connecting to local exhaust ventilation when purging the
cabinet if the cabinet is not hard ducted.
61
Table 13











Jones Lab 1.15 Overnight decon-area
II 88-A02 II 3H 3720 1020 <det. limit II
H 88-A04 6-16 Impinger 360 II Area sample after neut.
II 88-A05 II DuP C-60 360 0.16 M
II 88-A06 11 3M 3720 360 <det. limit ..»-"'
II 88-A07 II Bacharach 360 II 1
II 88-A08 It vapor-trak 290 0.02 H
H 88-01 6-15 DuP C-60 75 0.6 Personal during set-up
n 88-02 II 3M 3720 75 <det. limit 11
H 88-03 6-16 3M 3720 350 II Personal after neutrili
n 88-04 II Bacharach 340 >1.61 II
II 88-05 II ORBO-22 350 0.07 II
Carl Lab 88-A31 8-10 DuP C-60 402 0.17 Area during decon.
H 88-A32 II ORBO-22 407 <det. limit II
H 88-40 II DuP C-60 383 0.09 PersonaI-cert. asst.
a 88-41 II II II 0.21 Personal-decon. tech.
H 88-42 II Vapor-trak 15 <det. limit Paraform. addition
n 88-43 II II 15 II Cabinet purge
White 88-A33 8-11 ORBO-22 280 H Area during decon.
II 88-A34 II Vapor-trak II II II
H 88-45 II OuP C-60 250 0.60 Personal during decon.
CM. 88-A37 8-24 DuP C-60 840 0.12 Overnight decon.-area
11 88-A38 8-25 11 395 0.47 Area during decon.-
H 88-A39 11 ORBO-22 405 <det. limit no neutr.
« 88-58 II DUP C-60 240 0.18 Personal during decon.
II 88-59 II Vapor-trak 15 <det. limit Personal during purge
Blue 88-A40 8-26 ORBO-22 250 <det. limit Area during decon.
11 88-A41 II Vapor-trak II 0.07 II
ͣ 88-60 II II 250 0.06 Personal during decon.
II 88-61 II II 15 1.53 During Purge
RP #3 88-A43 9-29 DuP C-60 270 0.17 Area during decon.
II 88-A44 II Impinger II 0.01 II
u 88-77 II DuP C-60 280 0.33 Personal-decon. tech.
H 88-78 II II II 0.17 PersonaI-cert. asst.
n 88-79 II Vapor-trak 15 0.68 Personal-cabinet pruge
n 88-80 II Impinger 15 0.27 II
White = South Hospital White Zone
CM. = Clinical Microbiology Lab
Blue = South Hospital Blue zone
RP #3 = Research Park Building Nunber 3
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C.  Different areas that dilute 37.0 to 40.0% formaldehyde
solution to make different strength formalin solutions are
included together because there are so many different areas
and because the procedures are similar.  The only major
difference between each area is the volume of solution made.
The largest volume producer of formalin is the Pharmacy
Department.  One person from Pharmacy is responsible for
periodically mixing sixty gallons of 10.0% formalin
solution.  This is done in a stainless steel vat in a
building called the "vault" outside of the hospital.  If the
weather is good, mixing in the vat is done outside the
vault.  If the weather is bad, the vat is set just inside
the door and all doors and vents in the vault are kept open
during mixing.  The operator wears gloves and an apron while
performing the mixing.
The procedure starts with filling the vat with fifty
gallons of distilled water.  Nine hundred and seven grams of
sodium acid phosphate (monobasic) is then added and the
mixer is turned on until it dissolves.  Two and one-half
pounds of dibasic sodium phosphate is then added and mixed
until it dissolves.  Six gallons of 37.0% formaldehyde
solution is then added and mixed well.  Distilled water is
added to bring the volume to sixty gallons and the entire
solution is mixed well. With a rubber hose attached to the
bottom of the vat, the mixture is pumped out of the vat into
one gallon plastic containers.  The containers are labeled
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and stored in the vault for later delivery to the Materials
Management Department.  The one gallon containers are
dispensed to various departments throughout the medical
center.  This operation takes place as needed, generally
every three to five weeks.  All sample results were well
below the OSHA PEL and are listed in Table 14.
Another large volume producer of formalin is the Autopsy
Laboratory.  Sixty gallons of formalin is mixed as needed,
generally every two to three weeks.  The dilution is done in
a small (approximately ten by ten feet) storage room
adjacent to the Autopsy office and takes approximately
fifteen minutes to complete.  The room has its own
ventilation and the technician wears gloves, an apron, and a
half-mask respirator while performing the dilution.  Three
gallons of 37.0% formaldehyde are added to two separate
thirty gallon containers, two cups of potassium acetate is
added to one container, then each container is filled with
water to thirty gallons using a hose.  The formalin is taken
from each container as needed out the bottom from a spout.
All fifteen minute short term samples were well below the
OSHA STEL and are listed in Table 14.
As previously mentioned, a daily dilution is done in
each of three separate areas of the Dialysis Department.  A
single seven liter batch is mixed once a day both in the
North Hospital Hemodialysis Unit and the Dialysis West Unit.
In North it is done at a sink in a room approximately six by
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Table 14











Pharmacy 0.16 60 gal dilution in vaul
II 88-12 II DuP C-60 30 0.21 II
11 88-13 II 3M 3720 30 <det. limit H
II 88-64 8-31 Vapor-trak 35 0.03 II
Autopsy 88-28 8-2 Impinger 15 0.56 60 gal. dilution
11 88-29 11 Vapor-trak 15 <det. limit u
II 88-51 8-16 II 15 u H
North 88-07 6-24 Impinger 9 H 7 liter dilution
Main 88-08 6-27 II 15 II 3-7 liter dilutions
II 88-21 7-20 Vapor-trak 15 4.11 3-3.5 I dilutions
II 88-25 7-21 II 15 12.42 II
11 88-53 8-17 II 12 <det. limit 2-9 I dilutions
II 88-57 8-24 II 15 II 3-9 I dilutions
II 88-68 9-1 II 10 H 2-3.5 I dilutions
M/I#316 88-37 8-9 II 15 M 65 ml dilution
M/I#328 88-70 9-19 II S3 0.03 gel prep-5 min dil
North = North Dialysis Unit
Main = Main Room of Dialysis Center
H/I #316 = Microbiology and Immunology Lab #316
M/I #328 = Microbiology and Immunology Lab #328
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nine feet and takes approximately five to ten minutes.  In
Dialysis West, the dilution is done in the women's bathroom
(approximately four by six feet) and takes five to ten
minutes.
The main room of the Dialysis Center makes up a larger
volume of formalin solution because of the greater number of
machines.  Generally two to four nine liter jugs of formalin
are mixed at the sink in a thirteen by sixteen foot utility
room behind the main room.  The dilution takes approximately
ten to twenty minutes and is done by a different person each
day.  There are two windows which some technicians preferred
to have open.  One technician chose to have a fan running
behind them while the windows were open.
Result of formaldehyde sampling during dilution for
these areas was typically well below the OSHA STEL. There
were two samples taken during dilution on successive days
that were above the STEL (88-21, 88-25).  In each case, as
in the formalin dumping operation done in the Histology
Laboratory described earlier, formalin solution was poured
down the sink while the tap water was running.  The first
day, the sample result was 4.11 ppm after pouring
approximately one liter of formalin in the sink. The second
day the sample result was 12.42 ppm after approximately
three liters had been poured down the sink.  Results of
samples taken after asking the technician not to run the tap
water while dumping formalin in the sink were all well below
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the STEL.  All results from Dialysis dilution can be found
in Table 14.
The Vivarium has four different people who make a
formaldehyde dilution in three separate areas.  The formalin
is used for specimen preservation after rat necropsies or
animal surgeries as described earlier.  A technician in the
Vivarium Pathology Laboratory will make five gallons of
10.0% formalin solution every three to four months.  This
operation is done under a hood and takes approximately ten
to fifteen minutes to complete.  One gallon of a 2.0%
formalin solution is made up from either a 37.0%
formaldehyde solution or 10.0% formalin solution every two
to three months in a separate laboratory. The dilution
takes only five to ten minutes but every day ten test tubes
are filled with ten milliliters of the 2.0% solution taking
approximately fifteen minutes.  In the second floor
Autopsy/Necropsy room twenty liters of 10.0% formalin is
made every six months.  This takes approximately fifteen
minutes but is done without a hood.  None of these
procedures described for the Vivarium were done during the
time of this study, therefore no samples were taken.  It was
assumed the exposure was represented by the larger volume
dilutions.
In the VA Hospital Pathology Laboratory, one of three or
four people make up ten liters of 10.0% formalin solution
every three or four months to use for specimen preservation.
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This procedure takes five to ten minutes and is done under a
hood.  No sampling was done.
Remaining areas that did dilutions did so in very small
quantities and only occasionally.  Three separate
laboratories in the Department of Microbiology and
Immunology diluted 37.0% foirmaldehyde to 20.0% formalin for
use in making Northern Blot gels.  Each laboratory has two
or three people that would make up thirty-two to fifty
milliliters of the formalin solution for gels.  The dilution
is done at a laboratory workbench and takes just a few
minutes to complete.  Northern Blot preparation will be
discussed in detail later in Section JD.
D.  There are a number of other uses of formaldehyde where
in most cases the use was so infrequent, sporadic, and small
that sampling could not be done.  All these areas are
included together as miscellaneous use.
Use of formaldehyde for making Northern Blot gels is
widespread but typically minimal and very sporadic.  Most
laboratories stated that when doing northern blots, the gels
can be made up two or three times a week for up to four or
five weeks.  But most said they could go for up to six
months before they did any northern blots.
The northern blots technique is used to denature DNA.
The gels are made up with 10.0 to 20.0% formalin and are
used to transfer the DNA samples to the northern blots for
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later study.  All but one laboratory cut up the gel to be
used in an enclosed machine the following day after
preparation.  Working with the gel typically took only ten
to twenty minutes.  One laboratory did the transfer by hand
by placing the gel on blotter paper, placing the northern
blot on top, and placing paper towels over both overnight to
absorb the buffer and transfer the sample from gel to blot.
All but one laboratory did their own dilution of
formaldehyde solutions as described earlier, with the one
laboratory using Pharmacy-made 10.0% formalin.  Making the
formalin solution, pouring it into the gel, and working with
the gel were the only potential sources of exposure.  The
Department of Microbiology and Immunology had six different
laboratories that worked with northern blots.  Each
typically had four to six people that could do this type of
work. The Department of Medicine has two separate
laboratories, the Division of Neurology and the Division of
Hematology, that uses northern blots.  Two or three people
can do this work in each of these two laboratories under a
hood, but it only occurs approximately every six months.
Fifteen minute samples were taken during dilution in one
laboratory and long term samples were taken in the one
laboratory that did the transfer by hand. None of the other
laboratories worked with northern blots during the course of
this study. All sample results were well below the OSHA PEL
and STEL and are listed in Table 15.
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Table 15









M/I#316 Vapor-trak <det. limit 65 ml dilution
M/I#328 88-70 9-19 Vapor-trak 53 0.03 Gel Preparation
II
88-72 9-20 DuP C-60 440 0.21 Transfer
M/I #316 = Microbiology and Immunology Lab #316
M/I #328 = Microbiology and Immunology Lab #328
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There are two areas that use 10.0% formalin solution to
drop slides in after doing a pap smear.  These two areas are
the Allergy and Pulmonary Clinic and the Emergency
Department.  Each one drops slides in a small bottle
containing forty to fifty milliliters of formalin.  In the
Allergy and Pulmonary Clinic, a doctor can do the pap smears
in one of three rooms.  The bottle is only open for a few
seconds at a time.  In the Emergency Room, there are two
rooms where pap smears are done once or twice in a week by
the physician on duty.  In both areas, the pap smears are
never scheduled so air sampling was difficult.  Both areas
received their bottles already filled with formalin from the
Pathology Laboratory and returned the bottles to Pathology
with the pap smear slides.
The VA Hospital Pathology Laboratory and one of the
Microbiology and Immunology Laboratories use 37.0%
formaldehyde solution on blood sample trays.  Two or three
drops of formaldehyde are put on each tray to sit overnight.
The following day someone reads each tray under a microscope
for a few minutes.  Each laboratory has just one person
assigned to do this procedure.  The VA Pathology Laboratory
does this very infrequently, normally does only four trays,
and might not read each one the next day.  The Microbiology
and Immunology Laboratory does this procedure every two to
three weeks and may have twenty or more trays at a time to
do.
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One of the Chemistry Department laboratories uses
formaldehyde to prepare reagents.  This is done every three
or four months by using paraformaldehyde.  Two grams of
paraformaldehyde is dissolved in solution under a hood.  No
more than five minutes is spent on weighing and adding the
paraformaldehyde to solution.
Sampling was done in the Microbiology and Immunology
Laboratory in the Research Park building number three during
both the formaldehyde addition to the trays and reading the
trays the next day.  Results were well below OSHA
regulations and are listed in Table 16.
Formaldehyde may react with ionic chloride compounds in
humid air to produce bis-chloromethyl ether (BCME) which has
been shown to be a powerful carcinogen.  OSHA has set an
eight hour TWA PEL for BCME of one part per billion (ppb).
Initial plans included taking air samples for BCME in
areas where chloride compounds are used, as in the Dialysis
Department where Clorox bleach is used to clean the dialysis
machines and equipment.  Due to time constraints and the
fact that the sampling method is very different than that
used for formaldehyde, it was decided that sampling could
not be done during this study.
It was then decided that a memo would be sent to all
areas storing formaldehyde with Clorox or any other chloride
compound instructing them to separate each so there would be
no chance of reaction.  The decision was later made not to
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Table 16
Sample Results from Areas Preparing Blood Sample Trays
Sample
Area   Sample #  Date    Method    Time (mins.)     PPM      ________Conments
Lab #109 88-30    8-3   Vapor-trak      8      <det. limit   16 trays done
II     88-34     8-4       "        340 " "
Lab #109 = Research Park Building #3 Lab #109
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send the memo after reviewing the results of two separate
50
studies.  Studies done by Kallos and Solomon  and by Tou
51
and Kallos  both concluded that BCME does not form at the
detection limit of 0.1 ppb after reacting formaldehyde vapor
with hydrogen chloride at concentrations of 100.0 ppm of
each or reacting aqueous hydrogen chloride with formaldehyde
vapor in concentrations of 2000.0 ppm.  They stated that
occupational health problems would not be expected from
hydrogen chloride and formaldehyde, since BCME is not formed
even at concentrations of these reactants significantly
50
above that which humans can tolerate.
VII.  CONCLUSIONS
Formaldehyde is used extensively in a medical center
environment.  A comprehensive exposure survey was needed at
the medical center because of formaldehyde's widespread use
and to help comply with OSHA's new formaldehyde standard.
A complete survey of areas that use formaldehyde
throughout the medical center was achieved.  An account of
type of use, frequency of use, work practices and
conditions, and exposure population was made.
The fact that so many procedures are non-routine and
infrequent makes sampling difficult in the time given for
any one study, but would be possible with continuing and
routine surveillance.  Each type of formaldehyde use was
represented by air sampling, if not each area. An attempt
was made to sample as many areas as possible, with sampling
being at least representative of areas that use formaldehyde
in much the same way.
All long term samples taken were below the OSHA eight
hour TWA PEL except for one area sample taken during the
decontamination of a biological safety cabinet.  Only two
long term personal samples were above the OSHA action level,
also during a decontamination procedure.  All follow-up
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samples after these three were well below the OSHA PEL.  All
but three fifteen minute short term samples were below the
OSHA STEL.  The three that were above the STEL were in two
separate areas with very similar procedures.  After changing
the procedure for both, follow-up samples were well below
the OSHA STEL.
It can be concluded from these results that exposure to
formaldehyde vapor at the medical center was at an
acceptable level and in compliance with OSHA.  With the
minimal usage in most areas, excellent work practices in
every area, and adequate engineering controls in heavy use
areas, it can be said that the potential health risk for
formaldehyde at the medical center is very low.  With
continued monitoring of formaldehyde exposures and an
increased awareness of the potential health risks through
education, the medical center can remain in compliance with
OSHA regulations and continue to provide safe working
conditions for its employees.
VIII.  RECOMMENDATIONS
Other than specific recommendations made for individual
areas, there are some general recommendations that apply to
formaldehyde sampling done at the medical center.
The first and most important recommendation is to review
the formalin distribution and formaldehyde purchasing
records every six months to a year.  This will help keep up
with who is using formaldehyde and possibly uncover new
areas that have started using it.  From these records it
will be possible to continue updating formaldehyde usage.
Sampling should be continued in the heavy use areas such
as Autopsy, Surgical Pathology, and Dialysis. Routine
monitoring should be scheduled to keep up with any changes
that are made with regard to handling procedures, personnel
changes, or working conditions.
With regard to sampling methods and analysis, a number
of cost effective techniques should be pursued.  Sample
analysis should continue to be done in-house by use of the
chromotropic acid/spectrophotometer method and by perfecting
the use of the Environmental Safety Department gas
chromatograph for sorbent tube analysis.  The most
inexpensive ways of formaldehyde sampling if in-house
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spectrophotometer analysis is available are the 13X
molecular sieves and the 3M 3721 diffusive monitor.  Both of
these sampling methods should be developed to provide the
least expensive means of continued routine sampling.
Finally, the Bacharach Air-Scan monitor should be looked at
more closely to provide results that can be obtained almost
immediately after sampling.
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TEH «   DESCRIPTION
'm\ FORKSLIN •• FORmLDEHYDE GL, 3.73C
,^J5Z-K0LflDEX
2054 BAG, BROWN Pfim 1£LB SIZE 12




170-4562-77272 Home Health Care Pharmacy ͣ 8
999-  -   Annual Physical Inventory RdvjBtnrnt £81-3878    3
1/GL 157-g2&3-73976 Surgical Pathology Lab ;   . ,                   220
170-4450-77318 Pediatric Units Support Services/;;5100 ^' 2
303-6369-73312 National Heart, Lung and Blood Institute 681-5332 J  G
830-2050-82050 Surgical Private Diagnostic Clin:  ' 5
938-  -   Cycle Counts-Ove*-lay Onhand C61-3376   £1
12/CS 170-1744-77420 OB/GYN Clinic £
170-1814-77188 Clinical Hematology Laboratory 3
830-4170-84171 Medical Private Diagnostic Clinic 1
1/EA 157-9219-73949 Department of Medicine           : 6BV5eS5 12
170-1413-77894 Minot Rehabilitation 63
170-1416-77897 CMSU-CorabinGd Medical Specialitit;, Unit 6
170-1438-77322 Clinical Speciality Unit 10
170-1455-77323 Prevost, Obstetrics and Gynecolo;/ 85
170-1469-77326 Williams, Obstetrics 5 Gynacolog,. £05
170-1569-77279 OPC Pharmacy 500
170-1738-77458 General Medical Clinic £75
170-1746-77470 Oral Surgery Clinic 30
170-1750-77474 General Surgical Clinic 684-62&0   53
170-2410-77831 Inpatient Unit, Eye Center £0
170-4230-77413 Central Production, Dietetics 5500
170-4450-77318 Pediatric Units Support Services 115100 80
170-4453-77216 Pediatric Units Support Services M5303 10
170-4460-77108 Surgical Units Support Services/:6ie0 132
170-4501-77253 Sterile Processing 653
170-4510-77280 Department of Anesthesia 100
170-4713-77170 Emergency Departrnent 137


















684-  1 gal/
5266  year
Tissue   Every-  As
preserva-   day   needed
tion
Gloves     Will      Dr. Crapo-6266 350 Bell Dldg.look   3 Labs from Chemistry storeroom
diluted to 3% as needed.
Dept. of Medicine, 684-  1 gal/






in Rpl-    5963-M. Herbstreith-technician
across    dilute lOO'i to 50°'. S;o make hyperdi
from Jones   zation solution.
Dept. of Medicine  684-  500ml/
Div. of Hematology 3377  year
Microbiology, Immu- 684-  500ml/





yels for  week
Northern
blots










Dr. R. Bast - 3377 - Jones Bldg.
Dr. R, Corley - 5669-6016 ^-^lOml
405» formald. used. Jones Bldg.
//315
Rheumatology, Immu- 684-  l/2gal
nology Research Lab 2746  year
Dept. of Pathology 684-  Gal/
VA transplant Lab  6964  year
Six pro-  once/



















Bldg.   5
behind VA
K.   Culler -  2746,2:':26  -   Laszlo Jakoi
dilution to 2% -  does   1/2 '.I.
Dr.  A.  Sanfilippo  -  2482
Beth Barnhill  286-0411
Julie  Fuller 286-6964
Dilute to 10% 5A oi, time
flPfEMbl^   Nai»v8£fc   -m£l.




Iho    foUowliKj    cacn-ilta    .11:0     foe    .1 I 1:    aaiiiplliiy    Uoiva    Cot    Ulie    iLitus     I 1 -i Lcj.l     t 11    tli.>    ocoa    oc    on    uliB    eniploya.)    Dliow.i.    Aftoc    tevlawlitliaao    cosulta    wlLh    tlio    oinployfiQ    ami    cjoctlhg    bQLh    3 I <J n« l:i) c a ;i ,     (ila.i.-,u    sinml    ii    (jojiy    l).->ck    ti)    Llilu    ilopn c L.1..J111    wh i I u    kooplnij    tl*eoclylnal    foe   yovic    fllea.     It    Liuito   <\ t o    .ii\y   C|ueatlons   plis.TnQ   cill     the    IJii v I t or>mci 11 U a 1    Safoty    Oo p.i 1: tiiiun t .
KMPf.OYER/MlEA   SAMIH. liO SAMl'l.E   DATE
SUUSTftNCE    .SAMPLED 1'El,/.ST EL' T . L . V .  I
SAMPLE    IIESULT,  TWA' »
METHOD:
COMMENTS 1
'     PEL"    PERHISSIllLE    Kj(POSUHK   LIMIT,STEL»    SHOUT   TEKM    EXPOSURE    LUlir    A.'i    SI;T    IIV    THE   GCCUPAl'I OlIAL    SAPETV    MID    HEALTH
AnMINISTPATIo'll    (OSIIA) .1     rl.V-    TIIRESHOLI)    Ll.'^UT   VAI.OE    llECOMtlEIIDED    I) Y   'I'llE    AMEIUCAU   COH [• ͣEll CMC K   OF   OOV E lllll lEHTAL     IIIDILIT HI AL   IIYC I KM I SI'S     (ALCIll)
**T.W.A.»   TIME   WEIIHM'ED    AVKIIAOE   BASED   UH    All    0    IIOUIl   HOIIK   SCHEDIM.K.
EMPLOYEE   SUHIATUHE
illl'EUVISOH   S IGHATUUE
DATE
DATE
